Want to join the conversation?
$CCE 2Q15 Call: Net sales down 2% and operating income grew 2% both in comparable and currency-neutral basis. Total volume declined 1%. On the territory basis, volume in both Great Britain and Continental Europe decreased 1%. Importantly, while our net pricing per case was down 1%, cost of sales per case down 3%, creating gross margin expansion.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?